Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy

View source ↗

Summary

A clinical trial update examining whether podocyturia can predict renal dysfunction in Fabry disease–related nephropathy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Fabry Disease | Status: UNKNOWN